CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Tampa, Florida, United States and 50 other locations
due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson'...
Phase 2
Tampa, Florida, United States and 27 other locations
SC reference formulation in participants with either relapsing multiple sclerosis (RMS) or primary progressive multiple sc...
Phase 2
Tampa, Florida, United States and 55 other locations
(Part 1), a single-ascending subcutaneous (SC) dose (Part 2), and multiple ascending SC doses (Part 3) of RO7121932 in participants with multiple...
Phase 1
Tampa, Florida, United States and 31 other locations
This study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosis...
Phase 2
Tampa, Florida, United States and 46 other locations
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...
Phase 4
Tampa, Florida, United States and 42 other locations
The purpose of this study is to provide efficacy and safety data for remibrutinib in patients with secondary progressive multiple sclerosis...
Phase 3
Tampa, Florida, United States of America and 163 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Tampa, Florida, United States and 202 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Bradenton, Florida, United States and 225 other locations
of remibrutinib after switching from ocrelizumab and compared to continuous ocrelizumab treatment, in patients living with relapsing multiple...
Phase 3
Tampa, Florida, United States and 98 other locations
Clinical trials
Research sites
Resources
Legal